STORY:
In October 2024, a 49-year-old man from Georgia was rushed to the ER with a large abdominal mass, ascites, and severe abdominal pain.
He was diagnosed with Stage 4 Diffuse Large B-Cell Lymphoma (DLBCL) in the mesentery, one of the most aggressive forms of lymphoma.
💉 He received one cycle of R-CHOP chemotherapy — but the side effects were so severe, he refused further treatment.
In January 2025, we started a high-dose repurposed drug protocol:
THE PROTOCOL:
📌 Ivermectin – 1 mg/kg/day
📌 Fenbendazole – 1332 mg/day (6 days on, 1 off)
📌 Supporting protocol from local integrative doctor focused on gut and immune health
No chemo. No radiation. Just Ivermectin, Fenbendazole, and metabolic support.
RESULTS:
🗓 April 25, 2025 (after 3 months on the protocol):
✅ CT Scan showed “significant treatment response”
✅ The previously massive abdominal tumor was reduced to a small 3×2 cm residual nodule
📉 Complete resolution of ascites and inflammatory changes
📅 Follow-up PET scheduled in 3 months to confirm full metabolic remission.
MY TAKE:
📌 In this case — the only protocol maintained for 3 months was Ivermectin and Fenbendazole.
And the cancer responded dramatically.
This is what happens when the right agents are used with precision — and the body is given what it needs to fight.
🧠 We’re not just killing cancer cells. We’re supporting the immune system, restoring metabolic control, and targeting the root of tumor resilience.
📈 Stage 4 to almost clean in 3 months — no chemo required.
Dr. William Makis MD
